Physician profile
Suman Jaswal
NPI 1578536223
$3,689.55
in general payments reported to CMS, 2019-2025
18 companies · $1,091 in 2025
The $1,091 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $527 · 2020: $521 · 2021: $576 · 2022: $299 · 2023: $398 · 2024: $277 · 2025: $1,091.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,765.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,765.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,157.47 | 2019-2025 | General - Therapies, Farapulse |
| Impulse Dynamics (USA) INC. | $828.78 | 2020-2023 | Optimizer |
| Medtronic, INC. | $544.57 | 2022-2025 | Micra, Aurora Ev-Icd Mri Surescan, Closurefast |
| Biotronik INC. | $416.44 | 2023-2025 | Amvia Edge, Biomonitor |
| Abbott Laboratories | $187.75 | 2019-2023 | Aveir |
| Medtronic Vascular, INC. | $165.94 | 2019-2020 | |
| Kestra Medical Technology Services, INC. | $84.96 | 2024-2025 | Assure Wcd |
| Amgen INC. | $52.19 | 2025 | Repatha |
| Novo Nordisk INC | $46.45 | 2024 | Ozempic, Rybelsus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $38.84 | 2024-2025 | Jardiance |
| Atricure, INC. | $27.50 | 2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $23.97 | 2025 | Lifevest |
| Kiniksa Pharmaceuticals International, Plc | $23.73 | 2024 | Arcalyst |
| Novartis Pharmaceuticals Corporation | $23.49 | 2024 | |
| Alnylam Pharmaceuticals INC. | $21.63 | 2025 | Onpattro |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $19.76 | 2025 | Inspire |
| E.R. Squibb & Sons, L.L.C. | $13.49 | 2025 | Eliquis |
| Janssen Pharmaceuticals, INC | $12.59 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suman Jaswal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.